LLSC webcast series


The LLSC webcast series is an interactive, educational showcase of the progress we have made in understanding, treating and managing blood cancers.

“I had lymphoma in 2005 and to hear of the breakthroughs in the past 12 + years is hopeful and amazing. Thank you for taking the time to put this together and thank you to the Dr and everyone for the research they continue to do." - Webcast Participant

Learn more by participating over the telephone and online in upcoming webcasts.

Visit this page to access virtual lectures, audio replays and program slides from past programs.


Immunotherapy: is using the immune system to tackle cancer a reality?

The newest form of cancer treatment is based on the concept that immune cells or antibodies that can recognize and kill cancer cells in the laboratory can then be given to patients to treat cancer. Several types of immunotherapy are either approved for use or are under study in clinical trials to determine their effectiveness in treating various types of cancer, including blood cancers.

The topics covered included:

  • Overview of immunotherapy
  • How immunotherapy works
  • Which patients are eligible for immunotherapy
  • Getting the latest treatments to patients


Dr. Denis Claude Roy

Dr. Denis Claude Roy
Professor of Medicine, Université de Montréal
Director of Research, CIUSSS Est-Ile-de-Montréal
CEO, CellCAN Regenerative Medicine and Cell Therapy Network
Scientific Director, Center of Excellence in Cell Therapy



This Webcast is made possible thanks to the support of


Previous Webcasts:

To watch:

And all past webcasts, click here.